Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.
2.

Fish scale crystals: an under-recognised cause of intestinal necrosis.

Bogaerts JMA, van der Hoeven JG, Arts EEA, van der Kolk BM, Brosens LA.

J Clin Pathol. 2019 Aug;72(8):567. doi: 10.1136/jclinpath-2018-205203. Epub 2019 Jun 8. No abstract available.

PMID:
31177083
3.

The value of 3D reconstructions in determining post-operative reduction in acetabular fractures: a pilot study.

Arts E, Nijsink H, Verhamme L, Biert J, Bemelman M, Brouwers L, van Wageningen B.

Eur J Trauma Emerg Surg. 2019 Jun 1. doi: 10.1007/s00068-019-01148-8. [Epub ahead of print]

PMID:
31154463
4.

Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance.

Mohammadzadeh N, Love RP, Gibson R, Arts EJ, Poon AFY, Chelico L.

Heliyon. 2019 Apr 16;5(4):e01498. doi: 10.1016/j.heliyon.2019.e01498. eCollection 2019 Apr.

5.

Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment.

Ball LJ, Venner C, Tirona RG, Arts E, Gupta K, Wiener JC, Koivu S, Silverman MS.

J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):e127-e134. doi: 10.1097/QAI.0000000000002063.

PMID:
31021987
6.

Construct, content and face validity of the eoSim laparoscopic simulator on advanced suturing tasks.

Leijte E, Arts E, Witteman B, Jakimowicz J, De Blaauw I, Botden S.

Surg Endosc. 2019 Jan 22. doi: 10.1007/s00464-018-06652-3. [Epub ahead of print]

PMID:
30671668
7.

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda.

Poon AFY, Ndashimye E, Avino M, Gibson R, Kityo C, Kyeyune F, Nankya I, Quiñones-Mateu ME, Arts EJ; The Ugandan Drug Resistance Study Team.

AIDS Res Ther. 2019 Jan 22;16(1):3. doi: 10.1186/s12981-019-0218-2.

8.

An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.

Shortridge MD, Wille PT, Jones AN, Davidson A, Bogdanovic J, Arts E, Karn J, Robinson JA, Varani G.

Nucleic Acids Res. 2019 Feb 20;47(3):1523-1531. doi: 10.1093/nar/gky1197.

9.

Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral Activity.

Paparisto E, Woods MW, Coleman MD, Moghadasi SA, Kochar DS, Tom SK, Kohio HP, Gibson RM, Rohringer TJ, Hunt NR, Di Gravio EJ, Zhang JY, Tian M, Gao Y, Arts EJ, Barr SD.

J Virol. 2018 Jun 13;92(13). pii: e00528-18. doi: 10.1128/JVI.00528-18. Print 2018 Jul 1.

10.

A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system.

Pankrac J, Klein K, McKay PF, King DFL, Bain K, Knapp J, Biru T, Wijewardhana CN, Pawa R, Canaday DH, Gao Y, Fidler S, Shattock RJ, Arts EJ, Mann JFS.

NPJ Vaccines. 2018 Jan 19;3:2. doi: 10.1038/s41541-017-0040-6. eCollection 2018.

11.

Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda.

Ndashimye E, Avino M, Kyeyune F, Nankya I, Gibson RM, Nabulime E, Poon AFY, Kityo C, Mugyenyi P, Quiñones-Mateu ME, Arts EJ.

AIDS Res Hum Retroviruses. 2018 May;34(5):404-414. doi: 10.1089/AID.2017.0205. Epub 2018 Feb 26.

12.

Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection.

Klein K, Nickel G, Nankya I, Kyeyune F, Demers K, Ndashimye E, Kwok C, Chen PL, Rwambuya S, Poon A, Munjoma M, Chipato T, Byamugisha J, Mugyenyi P, Salata RA, Morrison CS, Arts EJ.

PLoS Pathog. 2018 Jan 18;14(1):e1006754. doi: 10.1371/journal.ppat.1006754. eCollection 2018 Jan.

13.

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.

Gibson RM, Nickel G, Crawford M, Kyeyune F, Venner C, Nankya I, Nabulime E, Ndashimye E, Poon AFY, Salata RA, Kityo C, Mugyenyi P, Quiñones-Mateu ME, Arts EJ.

Infect Dis Poverty. 2017 Dec 4;6(1):163. doi: 10.1186/s40249-017-0377-0.

14.

Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses.

Racine T, Kobinger GP, Arts EJ.

AIDS Res Ther. 2017 Sep 12;14(1):55. doi: 10.1186/s12981-017-0179-2. Review.

15.

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, van Riel PLCM, Gabriel SE, Matteson EL, Kvien TK, Douglas K, Sandoo A, Arts E, Wållberg-Jonsson S, Innala L, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon C, Ramos VP, Yáñez IC, Sfikakis PP, Zampeli E, Gonzalez-Gay MA, Corrales A, Laar MV, Vonkeman HE, Meek I, Semb AG; A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA).

Ann Rheum Dis. 2018 Jan;77(1):48-54. doi: 10.1136/annrheumdis-2017-211735. Epub 2017 Sep 6.

16.

Postnatal Identification of Zika Virus Peptides from Saliva.

Zuanazzi D, Arts EJ, Jorge PK, Mulyar Y, Gibson R, Xiao Y, Bringel Dos Santos M, Machado MAAM, Siqueira WL.

J Dent Res. 2017 Sep;96(10):1078-1084. doi: 10.1177/0022034517723325.

PMID:
28825520
17.

Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.

Berendsen MLT, van Maaren MC, Arts EEA, den Broeder AA, Popa CD, Fransen J.

J Rheumatol. 2017 Sep;44(9):1325-1330. doi: 10.3899/jrheum.160670. Epub 2017 Jul 1.

PMID:
28668802
18.

Tribute to Mark Wainberg.

Arts EJ, Gatignol A, Mouland AJ, Liang C, Götte M, Soudeyns H.

Retrovirology. 2017 Jun 28;14(1):38. doi: 10.1186/s12977-017-0361-6. No abstract available.

19.

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.

Arts EE, Fransen J, Den Broeder AA, van Riel PLCM, Popa CD.

Ann Rheum Dis. 2017 Oct;76(10):1693-1699. doi: 10.1136/annrheumdis-2016-210997. Epub 2017 Jun 12.

PMID:
28606965
20.

Dr. Mark A. Wainberg (1945-2017): Provocateur, Activist, and Champion for AIDS Care and Research.

Arts EJ.

AIDS Res Hum Retroviruses. 2017 May;33(5):iii-iv. doi: 10.1089/aid.2017.29002.art. No abstract available.

PMID:
28475374
21.

An in vitro Model to Mimic Selection of Replication-Competent HIV-1 Intersubtype Recombination in Dual or Superinfected Patients.

Bagaya BS, Tian M, Nickel GC, Vega JF, Li Y, He P, Klein K, Mann JFS, Jiang W, Arts EJ, Gao Y.

J Mol Biol. 2017 Jul 7;429(14):2246-2264. doi: 10.1016/j.jmb.2017.04.016. Epub 2017 May 1.

22.

Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.

Krebs KC, Tian M, Asmal M, Ling B, Nelson K, Henry K, Gibson R, Li Y, Han W, Shattock RJ, Veazey RS, Letvin N, Arts EJ, Gao Y.

AIDS Res Ther. 2016 Nov 25;13(1):41. doi: 10.1186/s12981-016-0125-8.

23.

First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.

Choi E, Michalski CJ, Choo SH, Kim GN, Banasikowska E, Lee S, Wu K, An HY, Mills A, Schneider S, Bredeek UF, Coulston DR, Ding S, Finzi A, Tian M, Klein K, Arts EJ, Mann JF, Gao Y, Kang CY.

Retrovirology. 2016 Nov 28;13(1):82.

24.

A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression.

Johnson AL, Dirk BS, Coutu M, Haeryfar SM, Arts EJ, Finzi A, Dikeakos JD.

mSphere. 2016 Nov 9;1(6). pii: e00288-16. eCollection 2016 Nov-Dec.

25.

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa.

Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, Rwambuya S, Munjoma M, Chipato T, Byamugisha J, Van Der Pol B, Mugyenyi P, Salata RA, Morrison CS, Arts EJ.

EBioMedicine. 2016 Nov;13:305-314. doi: 10.1016/j.ebiom.2016.10.014. Epub 2016 Oct 12.

26.

Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections.

Asmal M, Lane S, Tian M, Nickel G, Venner C, Dirk B, Dikeakos J, Luedemann C, Mach L, Balachandran H, Buzby A, Rao S, Letvin N, Gao Y, Arts EJ.

Virology. 2016 Dec;499:298-312. doi: 10.1016/j.virol.2016.09.021. Epub 2016 Oct 7.

27.

Duhamel versus transanal endorectal pull through (TERPT) for the surgical treatment of Hirschsprung's disease.

Arts E, Botden SM, Lacher M, Sloots P, Stanton MP, Sugarman I, Wester T, de Blaauw I.

Tech Coloproctol. 2016 Oct;20(10):677-82. doi: 10.1007/s10151-016-1524-5. Epub 2016 Sep 14.

28.

Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing.

Kenyon J, Nickel-Meester G, Qing Y, Santos-Guasch G, Drake E, PingfuFu, Sun S, Bai X, Wald D, Arts E, Gerson SL.

Int J Stem Cell Res Ther. 2016;3(2). pii: 031. Epub 2016 May 24.

29.

Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.

Kievit W, Maurits JS, Arts EE, van Riel PL, Fransen J, Popa CD.

Arthritis Care Res (Hoboken). 2017 Feb;69(2):175-182. doi: 10.1002/acr.22929.

30.

Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.

Kyeyune F, Gibson RM, Nankya I, Venner C, Metha S, Akao J, Ndashimye E, Kityo CM, Salata RA, Mugyenyi P, Arts EJ, Quiñones-Mateu ME.

Antimicrob Agents Chemother. 2016 May 23;60(6):3380-97. doi: 10.1128/AAC.00038-16. Print 2016 Jun.

31.

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

Tebit DM, Patel H, Ratcliff A, Alessandri E, Liu J, Carpenter C, Plantier JC, Arts EJ.

AIDS Res Hum Retroviruses. 2016 Jul;32(7):676-88. doi: 10.1089/AID.2015.0318. Epub 2016 Mar 16.

32.

Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.

Nankya IL, Tebit DM, Abraha A, Kyeyune F, Gibson R, Jegede O, Nickel G, Arts EJ.

AIDS Res Ther. 2015 Oct 3;12:34. doi: 10.1186/s12981-015-0066-7. eCollection 2015.

33.

Functional bottlenecks for generation of HIV-1 intersubtype Env recombinants.

Bagaya BS, Vega JF, Tian M, Nickel GC, Li Y, Krebs KC, Arts EJ, Gao Y.

Retrovirology. 2015 May 23;12:44. doi: 10.1186/s12977-015-0170-8.

34.

Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.

Shytaj IL, Nickel G, Arts E, Farrell N, Biffoni M, Pal R, Chung HK, LaBranche C, Montefiori D, Vargas-Inchaustegui D, Robert-Guroff M, Lewis MG, Sacha JB, Palamara AT, Savarino A.

J Virol. 2015 Aug;89(15):7521-35. doi: 10.1128/JVI.00396-15. Epub 2015 May 13.

35.

SiRNA-induced mutation in HIV-1 polypurine tract region and its influence on viral fitness.

Rausch JW, Tian M, Li Y, Angelova L, Bagaya BS, Krebs KC, Qian F, Zhu C, Arts EJ, Le Grice SF, Gao Y.

PLoS One. 2015 Apr 10;10(4):e0122953. doi: 10.1371/journal.pone.0122953. eCollection 2015.

36.

Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.

Arts EE, Popa CD, Den Broeder AA, Donders R, Sandoo A, Toms T, Rollefstad S, Ikdahl E, Semb AG, Kitas GD, Van Riel PL, Fransen J.

Ann Rheum Dis. 2016 Apr;75(4):674-80. doi: 10.1136/annrheumdis-2014-206879. Epub 2015 Feb 17.

PMID:
25691119
37.

Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2015 Apr;31(4):421-7. doi: 10.1089/AID.2014.0081. Epub 2014 Nov 19.

38.

Serum samples that have been stored long-term (>10 years) can be used as a suitable data source for developing cardiovascular risk prediction models in large observational rheumatoid arthritis cohorts.

Arts EE, Popa CD, Smith JP, Arntz OJ, van de Loo FA, Donders R, Semb AG, Kitas GD, van Riel PL, Fransen J.

Biomed Res Int. 2014;2014:930925. doi: 10.1155/2014/930925. Epub 2014 Sep 11.

39.

Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina.

Rubio AE, Abraha A, Carpenter CA, Troyer RM, Reyes-Rodríguez ÁL, Salomon H, Arts EJ, Tebit DM.

PLoS One. 2014 Apr 11;9(4):e92084. doi: 10.1371/journal.pone.0092084. eCollection 2014.

40.

Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds.

Liu Y, Rao U, McClure J, Konopa P, Manocheewa S, Kim M, Chen L, Troyer RM, Tebit DM, Holte S, Arts EJ, Mullins JI.

PLoS One. 2014 Apr 8;9(4):e94240. doi: 10.1371/journal.pone.0094240. eCollection 2014.

41.

Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.

Longosz AF, Morrison CS, Chen PL, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):390-6. doi: 10.1097/QAI.0000000000000006.

42.

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.

Arts EE, Fransen J, den Broeder AA, Popa CD, van Riel PL.

Ann Rheum Dis. 2015 Jun;74(6):998-1003. doi: 10.1136/annrheumdis-2013-204531. Epub 2014 Jan 23.

PMID:
24458537
43.

Engineered micro-objects as scaffolding elements in cellular building blocks for bottom-up tissue engineering approaches.

Leferink A, Schipper D, Arts E, Vrij E, Rivron N, Karperien M, Mittmann K, van Blitterswijk C, Moroni L, Truckenmüller R.

Adv Mater. 2014 Apr 23;26(16):2592-9. doi: 10.1002/adma.201304539. Epub 2014 Jan 7.

PMID:
24395427
44.

Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

Arts EE, Popa C, Den Broeder AA, Semb AG, Toms T, Kitas GD, van Riel PL, Fransen J.

Ann Rheum Dis. 2015 Apr;74(4):668-74. doi: 10.1136/annrheumdis-2013-204024. Epub 2014 Jan 3.

PMID:
24389293
45.

Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African Women.

Lemonovich TL, Watkins RR, Morrison CS, Kwok C, Chipato T, Musoke R, Arts EJ, Nankya I, Salata RA.

J Int Assoc Provid AIDS Care. 2015 Sep-Oct;14(5):415-22. doi: 10.1177/2325957413504827. Epub 2013 Oct 8.

46.

Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period.

Kyeyune F, Nankya I, Metha S, Akao J, Ndashimye E, Tebit DM, Rodriguez B, Kityo C, Salata RA, Mugyenyi P, Arts E; JCRC Drug Resistance Working Group.

AIDS. 2013 Jul 31;27(12):1899-909.

47.

Multifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc.

Lobritz MA, Ratcliff AN, Marozsan AJ, Dudley DM, Tilton JC, Arts EJ.

Antimicrob Agents Chemother. 2013 Jun;57(6):2640-50. doi: 10.1128/AAC.02511-12. Epub 2013 Mar 25.

48.

Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

Weber J, Vazquez AC, Winner D, Gibson RM, Rhea AM, Rose JD, Wylie D, Henry K, Wright A, King K, Archer J, Poveda E, Soriano V, Robertson DL, Olivo PD, Arts EJ, Quiñones-Mateu ME.

J Clin Microbiol. 2013 May;51(5):1517-27. doi: 10.1128/JCM.00092-13. Epub 2013 Mar 13.

49.

A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation.

Chamanian M, Purzycka KJ, Wille PT, Ha JS, McDonald D, Gao Y, Le Grice SF, Arts EJ.

Cell Host Microbe. 2013 Feb 13;13(2):181-92. doi: 10.1016/j.chom.2013.01.007.

50.

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.

Archer J, Weber J, Henry K, Winner D, Gibson R, Lee L, Paxinos E, Arts EJ, Robertson DL, Mimms L, Quiñones-Mateu ME.

PLoS One. 2012;7(11):e49602. doi: 10.1371/journal.pone.0049602. Epub 2012 Nov 14.

Supplemental Content

Support Center